{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:12:07Z","timestamp":1773378727246,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10072-023-07058-3","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:01:49Z","timestamp":1694066509000},"page":"709-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-7000","authenticated-orcid":false,"given":"Hongjing","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xutao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"issue":"5","key":"7058_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3174\/ajnr.A5141","volume":"38","author":"G Orman","year":"2017","unstructured":"Orman G, Wang KY, Pekcevik Y, Thompson CB, Mealy M, Levy M et al (2017) Enhancing brain lesions during acute optic neuritis and\/or longitudinally extensive transverse myelitis may portend a higher relapse rate in neuromyelitis optica spectrum disorders. AJNR Am J Neuroradiol 38(5):949\u2013953","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"7058_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/jnnp-2011-300434","volume":"83","author":"F Shimizu","year":"2012","unstructured":"Shimizu F, Sano Y, Takahashi T, Haruki H, Saito K, Koga M et al (2012) Sera from neuromyelitis optica patients disrupt the blood-brain barrier. J Neurol Neurosurg Psychiatry 83(3):288\u2013297","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7058_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fneur.2018.00648","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhu M, Liu C et al (2018) Blood brain barrier permeability could be a biomarker to predict severity of neuromyelitis optica spectrum disorders: a retrospective analysis. Front Neurol 9:648","journal-title":"Front Neurol"},{"key":"7058_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/2051-5960-2-48","volume":"2","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Verkman AS (2014) Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun 2:48","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"7058_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12264-015-1552-6","volume":"31","author":"M Li","year":"2015","unstructured":"Li M, Yan Y (2015) Experimental models of neuromyelitis optica: current status, challenges and future directions. Neurosci Bull 31(6):735\u2013744","journal-title":"Neurosci Bull"},{"issue":"1","key":"7058_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bpa.12098","volume":"24","author":"M Bradl","year":"2014","unstructured":"Bradl M, Lassmann H (2014) Experimental models of neuromyelitis optica. Brain Pathol 24(1):74\u201382","journal-title":"Brain Pathol"},{"issue":"10","key":"7058_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jnnp-2014-308095","volume":"86","author":"S Masuda","year":"2015","unstructured":"Masuda S, Mori M, Arai K, Uzawa A, Muto M, Uchida T, Masuda H, Kuwabara S (2015) Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry 86(10):1137\u20131142","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"7058_CR8","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hern\u00e1n MA, Olek MJ, Hankinson SE, Hunter DJ (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 286(24):3083\u20133088","journal-title":"JAMA."},{"issue":"11","key":"7058_CR9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","volume":"68","author":"SH Kim","year":"2011","unstructured":"Kim SH, Kim W, Li XF, Jung IJ, Kim HJ (2011) Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol 68(11):1412\u20131420","journal-title":"Arch Neurol"},{"issue":"7","key":"7058_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneurol.2011.148","volume":"68","author":"A Uzawa","year":"2011","unstructured":"Uzawa A, Mori M, Masuda S, Kuwabara S (2011) Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica. Arch Neurol 68(7):913\u2013917","journal-title":"Arch Neurol"},{"key":"7058_CR11","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.msard.2019.101880","volume":"38","author":"B Chen","year":"2020","unstructured":"Chen B, Qin C, Tao R, Dong YJ, Ma X, Chen M et al (2020) The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 38:101880","journal-title":"Mult Scler Relat Disord"},{"key":"7058_CR12","doi-asserted-by":"publisher","first-page":"104504","DOI":"10.1016\/j.msard.2023.104504","volume":"70","author":"C Yuan","year":"2023","unstructured":"Yuan C, Liu X, Cai S, Zhang L, Guo R, Jia Z et al (2023) Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 70:104504","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"7058_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/ane.13401","volume":"143","author":"A Olsson","year":"2021","unstructured":"Olsson A, Gustavsen S, Gissel\u00f8 Lauridsen K, Chenoufi Hasselbalch I, Sellebjerg F, Bach S\u00f8ndergaard H et al (2021) Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: a systematic review. Acta Neurol Scand 143(6):577\u2013586","journal-title":"Acta Neurol Scand"},{"key":"7058_CR14","doi-asserted-by":"publisher","first-page":"103514","DOI":"10.1016\/j.msard.2022.103514","volume":"58","author":"WC Huang","year":"2022","unstructured":"Huang WC, Lin HC, Yang YH, Hsu CW, Chen NC, Tsai WC et al (2022) Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio are associated with a 2-year relapse in patients with multiple sclerosis. Mult Scler Relat Disord 58:103514","journal-title":"Mult Scler Relat Disord"},{"issue":"3-4","key":"7058_CR15","first-page":"269","volume":"61","author":"H Fu","year":"2015","unstructured":"Fu H, Qin B, Hu Z et al (2015) Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab 61(3-4):269\u2013273","journal-title":"Clin Lab"},{"key":"7058_CR16","doi-asserted-by":"publisher","first-page":"103507","DOI":"10.1016\/j.msard.2022.103507","volume":"58","author":"E Carnero Contentti","year":"2022","unstructured":"Carnero Contentti E, L\u00f3pez PA, Criniti J, Pettinicchi JP, Cristiano E, Patrucco L et al (2022) Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability. Mult Scler Relat Disord 58:103507","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"7058_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12883-021-02432-0","volume":"21","author":"H Xie","year":"2021","unstructured":"Xie H, Zhao Y, Pan C, Zhang J, Zhou Y, Li Y et al (2021) Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study. BMC Neurol 21(1):389","journal-title":"BMC Neurol"},{"issue":"10","key":"7058_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s10072-017-3068-5","volume":"38","author":"J Lin","year":"2017","unstructured":"Lin J, Xue B, Li J, Xu H, Huang X, Yao Z et al (2017) Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurol Sci 38(10):1859\u20131863","journal-title":"Neurol Sci"},{"key":"7058_CR19","doi-asserted-by":"publisher","first-page":"104078","DOI":"10.1016\/j.msard.2022.104078","volume":"67","author":"YX Zhang","year":"2022","unstructured":"Zhang YX, Pu JL, Cai MT, Tao QQ, Tian J, Shen CH et al (2022) Inflammatory markers of hemogram parameters as predictive factors for disease severity in anti-N-methyl-D-aspartate receptor encephalitis. Mult Scler Relat Disord. 67:104078","journal-title":"Mult Scler Relat Disord."},{"key":"7058_CR20","doi-asserted-by":"publisher","first-page":"102604","DOI":"10.1016\/j.msard.2020.102604","volume":"47","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wu Y, Cao X, Li J, Liao X, Wei J et al (2021) The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord 47:102604","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"7058_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85(2):177\u2013189","journal-title":"Neurology."},{"issue":"2","key":"7058_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber H (2001) Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310(2):173\u2013186","journal-title":"Clin Chim Acta"},{"issue":"11","key":"7058_CR23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33(11):1444\u20131452","journal-title":"Neurology."},{"issue":"1","key":"7058_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00415-017-8676-8","volume":"265","author":"D Conradsson","year":"2018","unstructured":"Conradsson D, Ytterberg C, von Koch L, Johansson S (2018) Changes in disability in people with multiple sclerosis: a 10-year prospective study. J Neurol 265(1):119\u2013126","journal-title":"J Neurol"},{"issue":"1","key":"7058_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s12913-017-2807-x","volume":"17","author":"A Sicras-Mainar","year":"2017","unstructured":"Sicras-Mainar A, Ru\u00edz-Beato E, Navarro-Artieda R, Maurino J (2017) Impact on healthcare resource utilization of multiple sclerosis in Spain. BMC Health Serv Res 17(1):854","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"7058_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.21037\/apm.2019.12.12","volume":"9","author":"S Liang","year":"2020","unstructured":"Liang S, Qin Q, Tang Y, Liao W, Yang Y, He J et al (2020) Impact of blood-brain barrier disruption on newly diagnosed neuromyelitis optica spectrum disorder symptoms and prognosis. Ann Palliat Med 9(2):324\u2013330","journal-title":"Ann Palliat Med"},{"issue":"8","key":"7058_CR27","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1177\/1352458516672015","volume":"23","author":"T Uchida","year":"2017","unstructured":"Uchida T, Mori M, Uzawa A, Masuda H, Muto M, Ohtani R et al (2017) Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption. Mult Scler 23(8):1072\u20131084","journal-title":"Mult Scler"},{"key":"7058_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jocn.2022.05.002","volume":"101","author":"Z Duan","year":"2022","unstructured":"Duan Z, Feng J (2022) Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults. J Clin Neurosci 101:89\u201393","journal-title":"J Clin Neurosci"},{"key":"7058_CR29","doi-asserted-by":"publisher","first-page":"103527","DOI":"10.1016\/j.msard.2022.103527","volume":"59","author":"CC Fu","year":"2022","unstructured":"Fu CC, Gao C, Zhang HH et al (2022) Serum molecular biomarkers in neuromyelitis optica and multiple sclerosis. Mult Scler Relat Disord 59:103527","journal-title":"Mult Scler Relat Disord"},{"issue":"6214","key":"7058_CR30","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1256478","volume":"346","author":"V Sreeramkumar","year":"2014","unstructured":"Sreeramkumar V, Adrover JM, Ballesteros I et al (2014) Neutrophils scan for activated platelets to initiate inflammation. Science 346(6214):1234\u20131238","journal-title":"Science."}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07058-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:56:27Z","timestamp":1705467387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7058"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07058-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the University of Han Dan First Hospital: Protocol Number 20210117. Written informed consent was obtained from each participant or his\/her legal guardian. This study was conducted according to the principles expressed in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}